Oaktree Acquisition Corp. Iii Life Sciences · NASDAQ:OACC
Barclays PLC reported a 6.99% stake in Oaktree Acquisition Corp. Iii Life Sciences (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 13, 2026
Barclays PLC reported a 6.99% stake in Oaktree Acquisition Corp. Iii Life Sciences, 1,384,810 shares, as a passive investor on Jun 30, 2026. Filed Aug 13, 2026 (Schedule 13G).
- Stake
- 6.99%
- Shares
- 1,384,810
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Barclays PLC | 6.99% | 1,384,810 |
Source
Related
- Oaktree Acquisition Corp. Iii Life Sciences
- Barclays PLC
- Oaktree Acquisition Corp. Iii Life Sciences shareholders
- Schedule 13G/A · Barclays PLC · Feb 11, 2026
- Schedule 13G · Barclays PLC · May 13, 2025
- Form 4 · Oaktree Acquisition Holdings III LS, LLC · Oct 23, 2026
- Schedule 13G · Decagon Asset Management LLP · Aug 14, 2026
- Schedule 13G · Fort Baker Capital Management LP · May 15, 2026
- Schedule 13G · Goldman Sachs Group Inc · May 11, 2026
- Schedule 13G/A · Goldman Sachs Group Inc · Aug 12, 2025